01 10Alexion Pharma Canada, AstraZeneca Rare Disease
01 52559228
02 52687001
01 10ASFOTASE ALFA
01 10SOLUTION
01 52025-04-21
02 52028-05-12
Patent Expiration Date : 2025-04-21
Date Granted : 2016-06-21
Brand Name : STRENSIQ
Patent Number : 2559228
Filing Date : 2005-04-21
Strength per Unit : 40 mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2025-04-21
Date Granted : 2016-06-21
Patent Expiration Date : 2025-04-21
Date Granted : 2016-06-21
Brand Name : STRENSIQ
Patent Number : 2559228
Filing Date : 2005-04-21
Strength per Unit : 40 mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2025-04-21
Date Granted : 2016-06-21
Patent Expiration Date : 2025-04-21
Date Granted : 2016-06-21
Brand Name : STRENSIQ
Patent Number : 2559228
Filing Date : 2005-04-21
Strength per Unit : 40 mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2025-04-21
Date Granted : 2016-06-21
Patent Expiration Date : 2025-04-21
Date Granted : 2016-06-21
Brand Name : STRENSIQ
Patent Number : 2559228
Filing Date : 2005-04-21
Strength per Unit : 40 mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2025-04-21
Date Granted : 2016-06-21
Patent Expiration Date : 2025-04-21
Date Granted : 2016-06-21
Brand Name : STRENSIQ
Patent Number : 2559228
Filing Date : 2005-04-21
Strength per Unit : 100 mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2025-04-21
Date Granted : 2016-06-21
Patent Expiration Date : 2028-05-12
Date Granted : 2019-02-12
Brand Name : STRENSIQ
Patent Number : 2687001
Filing Date : 2008-05-12
Strength per Unit : 40 mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2028-05-12
Date Granted : 2019-02-12
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2028-05-12
Date Granted : 2019-02-12
Brand Name : STRENSIQ
Patent Number : 2687001
Filing Date : 2008-05-12
Strength per Unit : 40 mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2028-05-12
Date Granted : 2019-02-12
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2028-05-12
Date Granted : 2019-02-12
Brand Name : STRENSIQ
Patent Number : 2687001
Filing Date : 2008-05-12
Strength per Unit : 40 mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2028-05-12
Date Granted : 2019-02-12
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2028-05-12
Date Granted : 2019-02-12
Brand Name : STRENSIQ
Patent Number : 2687001
Filing Date : 2008-05-12
Strength per Unit : 40 mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2028-05-12
Date Granted : 2019-02-12
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2028-05-12
Date Granted : 2019-02-12
Brand Name : STRENSIQ
Patent Number : 2687001
Filing Date : 2008-05-12
Strength per Unit : 100 mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2028-05-12
Date Granted : 2019-02-12
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
